Drug industry embraces new business strategies after tough year

Dec 09, 2009
A timely year-end analysis of the state of the pharmaceutical industry is scheduled for Chemical & Engineering News, ACS' weekly newsmagazine. Credit: American Chemical Society

As they pop the champagne corks to celebrate New Year's Eve, drug industry executives will likely be glad to put 2009 behind them. That's because pharmaceutical companies who make top-selling drugs for heart disease, asthma, and many other conditions had a tough year in the midst of mounting market pressures and a global recession. A timely year-end analysis of the state of the pharmaceutical industry is scheduled for the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

C&EN Senior Editor Susan Ainsworth points out in the magazine's cover story that in 2009 drug companies were plagued by patent expirations for superstar drugs, rising competition from generic drugs, and shrinking pipelines for big-ticket products. On top of that, pharmaceutical firms also faced the possibility of U.S. health care reform legislation that could lower future drug pricing and profits, according to the article.

But drug companies are fighting back. They are cutting costs, slashing jobs, and refocusing business units in an attempt to be leaner and more customer-focused, the article notes. It describes how many companies are setting up creative licensing deals, partnerships and acquisitions — including megamergers — to improve operating efficiencies and strengthen new product pipelines. Some companies are also broadening access to their medicines in both established and emerging markets. "The companies that execute well while transforming themselves to compete effectively in this environment will emerge on top," notes the CEO of one major pharmaceutical company.

More information: "Timely Transformation", This story is available at pubs.acs.org/cen/coverstory/87/8749cover.html

Source: American Chemical Society (news : web)

Explore further: Rooting out horse-meat fraud in the wake of a recent food scandal

add to favorites email to friend print save as pdf

Related Stories

Study: Pet care industry is booming

Jun 26, 2007

The American Chemical Society said U.S. pet owners spent $18.5 million last year on veterinary care, medications and other non-food pet supplies.

Component of asphalt eyed as new fuel source

Sep 23, 2009

The pavement material that cars drive on may wind up in their fuel tanks as scientists seek ways of transforming asphaltenes -- the main component of asphalt -- into an abundant new source of fuel, according to the cover ...

Recommended for you

A refined approach to proteins at low resolution

Sep 19, 2014

Membrane proteins and large protein complexes are notoriously difficult to study with X-ray crystallography, not least because they are often very difficult, if not impossible, to crystallize, but also because ...

Base-pairing protects DNA from UV damage

Sep 19, 2014

Ludwig Maximilian University of Munich researchers have discovered a further function of the base-pairing that holds the two strands of the DNA double helix together: it plays a crucial role in protecting ...

Smartgels are thicker than water

Sep 19, 2014

Transforming substances from liquids into gels plays an important role across many industries, including cosmetics, medicine, and energy. But the transformation process, called gelation, where manufacturers ...

Separation of para and ortho water

Sep 18, 2014

(Phys.org) —Not all water is equal—at least not at the molecular level. There are two versions of the water molecule, para and ortho water, in which the spin states of the hydrogen nuclei are different. ...

User comments : 0